Stratford Collins Associates Limited 31/03/2025 iXBRL

Company registration number: 07905739

Stratford Collins Associates Limited

Trading as Stratford Collins Associates

Unaudited filleted financial statements

31 March 2025

Stratford Collins Associates Limited

Contents

Directors and other information

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Stratford Collins Associates Limited

Directors and other information


	Directors	Mr Adrian Shakespeare
		Mr Steven Williams


	Company number	07905739


	Registered office	58 The Woodlands
		Brackla
		Bridgend
		CF31 2JG


	Business address	58 The Woodlands
		Brackla
		Bridgend
		CF31 2JG

Stratford Collins Associates Limited

Statement of financial position

31 March 2025

		2025		2024
	Note	£	£	£	£

Current assets
Debtors	4	58,917		78,892
Cash at bank and in hand		600		4,871
		_______		_______
		59,517		83,763
Creditors: amounts falling due
within one year	5	( 8,855)		( 23,288)
		_______		_______
Net current assets			50,662		60,475
			_______		_______
Total assets less current liabilities			50,662		60,475

			_______		_______
Net assets			50,662		60,475
			_______		_______

Capital and reserves
Called up share capital			100		100
Profit and loss account			50,562		60,375
			_______		_______
Shareholders funds			50,662		60,475
			_______		_______

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 16 December 2025 , and are signed on behalf of the board by:

Mr Adrian Shakespeare

Director

Company registration number: 07905739

Stratford Collins Associates Limited

Statement of changes in equity

Year ended 31 March 2025

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 April 2023	100	62,865	62,965

Loss for the year		( 2,490)	( 2,490)
	_______	_______	_______
Total comprehensive income for the year	-	( 2,490)	( 2,490)

	_______	_______	_______
At 31 March 2024 and 1 April 2024	100	60,375	60,475

Loss for the year		( 9,813)	( 9,813)
	_______	_______	_______
Total comprehensive income for the year	-	( 9,813)	( 9,813)

	_______	_______	_______
At 31 March 2025	100	50,562	50,662
	_______	_______	_______

Stratford Collins Associates Limited

Notes to the financial statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is 58 The Woodlands, Brackla, Bridgend, CF31 2JG.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Debtors

	2025	2024
	£	£
Other debtors	58,917	78,892
	_______	_______

5. Creditors: amounts falling due within one year

	2025	2024
	£	£
Bank loans and overdrafts	5,495	-
Corporation tax	-	19,928
Other creditors	3,360	3,360
	_______	_______
	8,855	23,288
	_______	_______

6. Directors advances, credits and guarantees

	During the year the directors entered into the following advances and credits with the company:

2025
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Adrian Shakespeare	66,250	( 8,950)	57,300
		_______	_______	_______

2024
		Balance brought forward	Advances /(credits) to the directors	Balance o/standing
		£	£	£
	Mr Adrian Shakespeare	29,350	36,900	66,250
		_______	_______	_______